Brown Brothers Harriman & Co. cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 37.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,513 shares of the company’s stock after selling 6,327 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Henry Schein were worth $766,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the business. Daiwa Securities Group Inc. raised its position in shares of Henry Schein by 11.4% in the 3rd quarter. Daiwa Securities Group Inc. now owns 15,636 shares of the company’s stock valued at $1,140,000 after purchasing an additional 1,596 shares during the last quarter. Cerity Partners LLC increased its stake in Henry Schein by 12.3% during the 3rd quarter. Cerity Partners LLC now owns 26,339 shares of the company’s stock valued at $1,920,000 after purchasing an additional 2,894 shares in the last quarter. Studio Investment Management LLC raised its holdings in shares of Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after buying an additional 172 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Henry Schein by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock worth $85,662,000 after buying an additional 6,184 shares during the period. Finally, Thompson Siegel & Walmsley LLC grew its holdings in shares of Henry Schein by 37.7% during the third quarter. Thompson Siegel & Walmsley LLC now owns 1,003,041 shares of the company’s stock valued at $73,122,000 after buying an additional 274,756 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.
Henry Schein Stock Up 0.6 %
HSIC opened at $77.28 on Wednesday. The company has a fifty day moving average of $71.03 and a two-hundred day moving average of $69.76. The stock has a market capitalization of $9.64 billion, a price-to-earnings ratio of 31.80, a PEG ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on HSIC shares. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Evercore ISI lifted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $78.89.
Get Our Latest Report on Henry Schein
Insider Transactions at Henry Schein
In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Investing In Automotive Stocks
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How to Start Investing in Real Estate
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.